AstraZeneca shares owned by Point72 Asset Management
Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Point72 Asset Management
from 13F filings
Historical chart of Point72 Asset Management investment in AstraZeneca
Tip: Access up to 7 years of quarterly data
All positions including AstraZeneca held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in AstraZeneca by Point72 Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $47M | 610k | 76.72 |
| 2025-06-30 | $121M | 1.7M | 69.88 |
| 2025-03-31 | $109M | 1.5M | 73.50 |
| 2024-12-31 | $70M | 1.1M | 65.52 |
| 2024-09-30 | $12M | 150k | 77.91 |
| 2024-06-30 | $39M | 499k | 77.99 |
| 2024-03-31 | $13M | 187k | 67.75 |
| 2023-12-31 | $20M | 292k | 67.35 |
| 2023-09-30 | $711k | 11k | 67.72 |
| 2023-06-30 | $775k | 11k | 71.57 |
| 2023-03-31 | $729k | 11k | 69.41 |
| 2022-12-31 | $156M | 2.3M | 67.80 |
| 2022-09-30 | $265M | 4.8M | 54.84 |
| 2022-06-30 | $132M | 2.0M | 66.07 |
| 2022-03-31 | $89M | 1.3M | 66.34 |
| 2021-12-31 | $103M | 1.8M | 58.25 |
| 2021-09-30 | $147M | 2.4M | 60.06 |
| 2021-06-30 | $108M | 1.8M | 59.90 |
| 2021-03-31 | $177M | 3.6M | 49.72 |
| 2020-12-31 | $212M | 4.2M | 49.99 |
| 2020-09-30 | $27M | 485k | 54.80 |
| 2020-06-30 | $37M | 695k | 52.89 |
| 2020-03-31 | $25M | 550k | 44.66 |
| 2019-06-30 | $120M | 2.9M | 41.28 |
| 2019-03-31 | $95M | 2.4M | 40.43 |
| 2018-12-31 | $19M | 493k | 37.98 |
| 2018-09-30 | $30M | 757k | 39.57 |
| 2018-06-30 | $98M | 2.8M | 35.11 |
| 2018-03-31 | $102M | 2.9M | 34.97 |
| 2017-12-31 | $32M | 925k | 34.70 |
| 2017-09-30 | $42M | 1.2M | 33.88 |
| 2017-06-30 | $21M | 603k | 34.09 |
| 2017-03-31 | $37M | 1.2M | 31.14 |
| 2016-12-31 | $19M | 676k | 27.32 |
| 2015-06-30 | $3.2M | 50k | 63.71 |
| 2015-03-31 | $4.2M | 62k | 68.43 |
| 2014-12-31 | $41M | 587k | 70.38 |
| 2014-09-30 | $72M | 1.0M | 71.44 |
| 2014-06-30 | $44M | 596k | 74.31 |